How critical is competitive advantage? Just ask Coinstar
The company issued a press release blandly stating that the former partners were unable to reach "mutually acceptable economic terms." Previous terms had included an 8.9% fee to Coinstar, with supermarket partners getting a 1% cut for housing the kiosks in their stores. Apparently, Safeway wanted more, and Coinstar was unwilling to bend.
The possibility of a Safeway defection had long been rumored due to trials of a competitor's product by Safeway Arizona, who had never been a Coinstar client. It's too early to say whether Safeway has intentions of rolling out the competing product on a larger-scale, but Coinstar's dominance is clearly at risk. Furthering those worries is the news revealed on today's conference call that Kroger
This is a classic case of juicy profit margins attracting competition. Over the past three years, Coinstar's free cash flow margins have averaged 10%, even while the company has aggressively expanded its kiosk network (over 10,000 machines at last count). Once the expansion slows, free cash flow margins could easily reach 20% or more. But only if Coinstar can maintain its current economic terms, which are obviously at risk.
Until Coinstar can prove that this risk is unfounded, the stock is vulnerable. At today's market cap of $294 million, Coinstar is valued at roughly 1.7 times projected 2003 sales. A normalized 10% free cash flow margin implies a price-to-free cash flow multiple of about 17. Even after today's 28% haircut, that's not yet cheap enough given the competitive risks. A price closer to 10 times free cash flow might offer a reasonable margin of safety.
More from The Motley Fool
Hate Checking Your Portfolio? Try These 2 High-Yield Stocks
If you agree with the notion that boring is good, then check out this energy company and this petroleum pipeline operator.
What Is a Family Limited Partnership?
Want a way to protect your family's wealth from the IRS? Enter the FLP.
Will This Tiny Biotech Be Celgene's Next Takeover Target?
Depending on data later this year, Celgene may want to buy this collaboration partner.